+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Calcium Channel Blocker"

From
Anti-Hypertensive Drugs Market Report and Forecast 2025-2034 - Product Thumbnail Image

Anti-Hypertensive Drugs Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Hypertrophic Cardiomyopathy Pipeline Analysis Report 2025 - Product Thumbnail Image

Hypertrophic Cardiomyopathy Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Hypertension Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Hypertension Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Cardiovascular Calcification Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Cardiovascular Calcification Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Atrial Fibrillation Pipeline Analysis Report 2025 - Product Thumbnail Image

Atrial Fibrillation Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

Calcium Channel Blockers (CCBs) are a class of drugs used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. They work by blocking the entry of calcium ions into the cells of the heart and blood vessels, thus reducing the force of contraction of the heart and dilating the blood vessels. This reduces the workload on the heart and lowers blood pressure. CCBs are also used to treat other conditions such as migraine headaches and Raynaud's phenomenon. CCBs are generally well tolerated and have few side effects. Common side effects include dizziness, headache, and swelling of the ankles. They may also interact with other medications, so it is important to discuss all medications with a doctor before taking CCBs. The CCB market is a major component of the cardiovascular drug market. It is a highly competitive market, with many companies offering a variety of CCBs. Some of the major companies in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more